OngoingEUCTR 2009-011594-33
This study is comparing RISPERIDONE with placebo for people with Schizophrenia. Participants receive RISPERIDONE or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- Germany
- Sponsor
- LWL University Hospital Bochum, Ruhr-University Bochum
- Condition
- Schizophrenia
OngoingEUCTR 2021-001333-38
This study is looking at whether BRINTELLIX can help people with Early schizophrenia. Participants receive the study medicine BRINTELLIX and complete study visits and assessments.
SchizophreniaOther
- Countries
- Spain
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
- Condition
- Schizophrenia
OngoingEUCTR 2017-001170-42
This study is comparing SODIUM BENZOATE with placebo for people with Treatment for Refractory Schizophrenia in. Participants receive SODIUM BENZOATE or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- Germany, United Kingdom, Poland
- Sponsor
- SyneuRx International (Taiwan) Corp
- Condition
- Schizophrenia
CompletedEUCTR 2017-001168-39
This study is comparing SODIUM BENZOATE with placebo for people with Treatment for Schizophrenia in Adolescents or Adolescents, Under 18. Participants receive SODIUM BENZOATE or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- Poland, United Kingdom
- Sponsor
- SyneuRx International (Taiwan) Corp
- Condition
- Schizophrenia
OngoingEUCTR 2017-001169-26
This study is comparing SODIUM BENZOATE with placebo for people with Treatment for Schizophrenia in. Participants receive SODIUM BENZOATE or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- United Kingdom, Poland
- Sponsor
- SyneuRx International (Taiwan) Corp
- Condition
- Schizophrenia
OngoingEUCTR 2019-001408-39
This study is comparing sertraline hydrochloride with placebo for people with Psychosis. Participants receive sertraline hydrochloride or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- United Kingdom, View results
- Sponsor
- Cardiff University
- Condition
- Schizophrenia
OngoingEUCTR 2007-007538-21
This study is looking at care and outcomes for people with Diagnosis of Schizophrenia in Male or female, as defined in Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revised and confirmed by the St. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOther
- Countries
- France
- Sponsor
- CYRENAIC
- Condition
- Schizophrenia
OngoingEUCTR 2013-001315-71
This study is looking at whether ARIPIPRAZOLE can help people with schizophrenia. Participants receive the study medicine ARIPIPRAZOLE and complete study visits and assessments.
SchizophreniaOther
- Countries
- Spain
- Sponsor
- Mercedes Zumarraga Ortiz
- Condition
- Schizophrenia
OngoingEUCTR 2021-000350-26
This study is looking at whether VAFIDEMSTAT can help people with Schizophrenia. Participants receive the study medicine VAFIDEMSTAT and complete study visits and assessments.
SchizophreniaOther
- Countries
- Spain
- Sponsor
- Oryzon Genomics, S.A.
- Condition
- Schizophrenia
OngoingEUCTR 2018-002740-82
This study is looking at care and outcomes for people with schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOther
- Countries
- United Kingdom, View results
- Sponsor
- Boehringer Ingelheim Limited
- Condition
- Schizophrenia
OngoingEUCTR 2019-002259-40
This study is looking at whether quetiapine fumarate can help people with Schizophrenia. Participants receive the study medicine quetiapine fumarate and complete study visits and assessments.
SchizophreniaOther
- Countries
- Romania, View results
- Sponsor
- Sunovion Pharmaceuticals Inc.
- Condition
- Schizophrenia
OngoingEUCTR 2013-002713-35
This study is comparing TOLCAPONE with placebo for people with schizophrenia. Participants receive TOLCAPONE or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- Greece
- Sponsor
- MediPsych SA
- Condition
- Schizophrenia
OngoingEUCTR 2008-001015-38
This study is comparing RISPERIDONE with placebo for people with Schizophrenia. Participants receive RISPERIDONE or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- Germany
- Sponsor
- LWL University Hospital Bochum, Ruhr-University Bochum
- Condition
- Schizophrenia
OngoingEUCTR 2004-002591-42
This study is looking at whether BIFEPRUNOX can help people with Schizophrenia or Elderly. Participants receive the study medicine BIFEPRUNOX and complete study visits and assessments.
SchizophreniaOther
- Countries
- Spain
- Sponsor
- H.Lundbeck A/S
- Condition
- Schizophrenia
OngoingEUCTR 2007-002245-20
This study is comparing Sitagliptin with placebo for people with Basic ressearch on schizophrenia. This is a proof-of-concept trial.
SchizophreniaOther
- Countries
- Germany
- Sponsor
- Zentralinstitut für Seelische Gesundheit Mannheim
- Condition
- Schizophrenia
OngoingEUCTR 2021-001278-44
This study is looking at whether CLOZAPINE can help people with Treatment-resistant schizophrenia and schizoafective disorder or Elderly. Participants receive the study medicine CLOZAPINE and complete study visits and assessments.
SchizophreniaOther
- Countries
- Spain
- Sponsor
- Fundación Hospital Provincial de Castellón
- Condition
- Schizophrenia
OngoingEUCTR 2016-000709-36
This study is looking at care and outcomes for people with Schizophrenia, delusional disorders, schizoaffective disorder, psychosis or Elderly. Direct benefit is not guaranteed, but the study may help researchers improve future care.
SchizophreniaOther
- Countries
- United Kingdom, View results
- Sponsor
- UCL
- Condition
- Schizophrenia
OngoingEUCTR 2015-001599-23
This study is looking at whether [11C]PK11195 can help people with Schizophrenia. Participants receive the study medicine [11C]PK11195 and complete study visits and assessments.
SchizophreniaOther
- Countries
- Netherlands
- Sponsor
- University Medical Center Groningen
- Condition
- Schizophrenia
OngoingEUCTR 2017-001739-38
This study is comparing TAK-831 with placebo for people with Schizophrenia. Participants receive TAK-831 or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- United Kingdom, View results
- Sponsor
- Takeda Development Centre Europe Ltd.
- Condition
- Schizophrenia
OngoingEUCTR 2010-018416-33
This study is looking at whether FENOFIBRATE MYLAN 200 mg, gélule can help people with schizophrénia or Elderly. Participants receive the study medicine FENOFIBRATE MYLAN 200 mg, gélule and complete study visits and assessments.
SchizophreniaOther
- Countries
- France
- Sponsor
- Centre Hospitalier Régional et Universitaire de Lille
- Condition
- Schizophrenia
CompletedEUCTR 2021-003834-34
This study is comparing Luvadaxistat with placebo for people with Cognitive Impairment Associated With Schizophrenia. Participants receive Luvadaxistat or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- Czech Republic, Spain, View results
- Sponsor
- Neurocrine Biosciences, Inc.
- Condition
- Schizophrenia
OngoingEUCTR 2006-002000-34
This study is looking at whether Leponex can help people with Schizophrenia. Participants receive the study medicine Leponex and complete study visits and assessments.
SchizophreniaOther
- Countries
- Spain
- Sponsor
- Fundación Cerebro y Mente
- Condition
- Schizophrenia
OngoingEUCTR 2006-002342-11
This study is looking at whether Quetiapine can help people with have to fulfill the diagnostic criteria of a schizophrenia according to DSM-IV. Participants receive the study medicine Quetiapine and complete study visits and assessments.
SchizophreniaOther
- Countries
- Germany
- Sponsor
- Klinikum Fulda gAG
- Condition
- Schizophrenia
OngoingEUCTR 2017-004064-35
This study is comparing LIRAGLUTIDE with placebo for people with Schizophrenia, schizoaffective disorder or first episode psychosis or Elderly. Participants receive LIRAGLUTIDE or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- United Kingdom
- Sponsor
- Southern Health NHS Foundation Trust
- Condition
- Schizophrenia
CompletedEUCTR 2018-003825-27
This study is comparing BIIB104 with placebo for people with Schizophrenia. Participants receive BIIB104 or placebo and complete study visits and assessments.
SchizophreniaOther
- Countries
- Germany, United Kingdom, View results
- Sponsor
- Biogen Idec Research Limited
- Condition
- Schizophrenia